Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Oncogenic roles of SMARCB1/INI1 and its deficient tumors.

Kohashi K, Oda Y.

Cancer Sci. 2017 Apr;108(4):547-552. doi: 10.1111/cas.13173. Epub 2017 Apr 12. Review.

2.

The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis.

Kehrer-Sawatzki H, Farschtschi S, Mautner VF, Cooper DN.

Hum Genet. 2017 Feb;136(2):129-148. doi: 10.1007/s00439-016-1753-8. Epub 2016 Dec 5. Review.

3.

Multiple Unilateral Vestibular Schwannomas: Segmental NF2 or Sporadic Occurrence?

Carlson ML, Van Gompel JJ.

J Neurol Surg Rep. 2016 Jun;77(2):e106-8. doi: 10.1055/s-0036-1584603.

4.

Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients.

Ostrow KL, Donaldson K, Blakeley J, Belzberg A, Hoke A.

PLoS One. 2015 Dec 14;10(12):e0144620. doi: 10.1371/journal.pone.0144620. eCollection 2015.

5.
6.

Segmental neurofibromatosis type 2: discriminating two hit from four hit in a patient presenting multiple schwannomas confined to one limb.

Castellanos E, Bielsa I, Carrato C, Rosas I, Solanes A, Hostalot C, Amilibia E, Prades J, Roca-Ribas F, Lázaro C, Blanco I, Serra E; NF2 Multidisciplinary Clinics HUGTiP-ICO-IMPPC.

BMC Med Genomics. 2015 Jan 24;8:2. doi: 10.1186/s12920-015-0076-2.

7.

Clinical response to bevacizumab in schwannomatosis.

Blakeley J, Schreck KC, Evans DG, Korf BR, Zagzag D, Karajannis MA, Bergner AL, Belzberg AJ.

Neurology. 2014 Nov 18;83(21):1986-7. doi: 10.1212/WNL.0000000000000997. Epub 2014 Oct 22. No abstract available.

8.

Primary atypical teratoid/rhabdoid tumor of central nervous system in children: a clinicopathological analysis and review of literature in China.

Yang M, Chen X, Wang N, Zhu K, Hu YZ, Zhao Y, Shu Y, Zhao ML, Gu WZ, Tang HF.

Int J Clin Exp Pathol. 2014 Apr 15;7(5):2411-20. eCollection 2014. Review.

9.

CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies.

Widemann BC, Acosta MT, Ammoun S, Belzberg AJ, Bernards A, Blakeley J, Bretscher A, Cichowski K, Clapp DW, Dombi E, Evans GD, Ferner R, Fernandez-Valle C, Fisher MJ, Giovannini M, Gutmann DH, Hanemann CO, Hennigan R, Huson S, Ingram D, Kissil J, Korf BR, Legius E, Packer RJ, McClatchey AI, McCormick F, North K, Pehrsson M, Plotkin SR, Ramesh V, Ratner N, Schirmer S, Sherman L, Schorry E, Stevenson D, Stewart DR, Ullrich N, Bakker AC, Morrison H.

Am J Med Genet A. 2014 Mar;164A(3):563-78. doi: 10.1002/ajmg.a.36312. Epub 2014 Jan 17.

10.

Clinical Neuropathology practice guide 6-2013: morphology and an appropriate immunohistochemical screening panel aid in the identification of synovial sarcoma by neuropathologists.

Keith JL, Bilbao J, Croul S, Ang LC, Guiot MC, Rossiter J, Ghorab Z, Hawkins C, Karamchandani J.

Clin Neuropathol. 2013 Nov-Dec;32(6):461-70. doi: 10.5414/NP300685.

11.

Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria.

Plotkin SR, Blakeley JO, Evans DG, Hanemann CO, Hulsebos TJ, Hunter-Schaedle K, Kalpana GV, Korf B, Messiaen L, Papi L, Ratner N, Sherman LS, Smith MJ, Stemmer-Rachamimov AO, Vitte J, Giovannini M.

Am J Med Genet A. 2013 Mar;161A(3):405-16. doi: 10.1002/ajmg.a.35760. Epub 2013 Feb 7.

12.

Expression of SMARCB1 (INI1) mutations in familial schwannomatosis.

Smith MJ, Walker JA, Shen Y, Stemmer-Rachamimov A, Gusella JF, Plotkin SR.

Hum Mol Genet. 2012 Dec 15;21(24):5239-45. doi: 10.1093/hmg/dds370. Epub 2012 Sep 4.

13.

The molecular biology of vestibular schwannomas and its association with hearing loss: a review.

Celis-Aguilar E, Lassaletta L, Torres-Martín M, Rodrigues FY, Nistal M, Castresana JS, Gavilan J, Rey JA.

Genet Res Int. 2012;2012:856157. doi: 10.1155/2012/856157. Epub 2012 Feb 20.

14.

Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromes.

Rodriguez FJ, Stratakis CA, Evans DG.

Acta Neuropathol. 2012 Mar;123(3):349-67. doi: 10.1007/s00401-011-0935-7. Epub 2011 Dec 31. Review.

15.

Epithelioid malignant peripheral nerve sheath tumor arising in a schwannoma, in a patient with "neuroblastoma-like" schwannomatosis and a novel germline SMARCB1 mutation.

Carter JM, O'Hara C, Dundas G, Gilchrist D, Collins MS, Eaton K, Judkins AR, Biegel JA, Folpe AL.

Am J Surg Pathol. 2012 Jan;36(1):154-60. doi: 10.1097/PAS.0b013e3182380802.

16.

Ossifying fibromyxoid tumor of soft parts: a clinicopathologic, proteomic, and genomic study.

Graham RP, Dry S, Li X, Binder S, Bahrami A, Raimondi SC, Dogan A, Chakraborty S, Souchek JJ, Folpe AL.

Am J Surg Pathol. 2011 Nov;35(11):1615-25. doi: 10.1097/PAS.0b013e3182284a3f.

17.

Polyradiculopathies from schwannomatosis.

Jia Y, Kraus JA, Reddy H, Groff M, Wong ET.

Open Neuroimag J. 2011;5:9-13. doi: 10.2174/1874440001105010009. Epub 2011 Jan 18.

18.

Superficial neurofibromas in the setting of schwannomatosis: nosologic implications.

Rodriguez FJ, Scheithauer BW, George D, Midha R, MacCollin M, Stemmer-Rachamimov AO.

Acta Neuropathol. 2011 May;121(5):663-8. doi: 10.1007/s00401-010-0793-8. Epub 2010 Dec 30.

19.

Molecular diagnostics of CNS embryonal tumors.

Pfister SM, Korshunov A, Kool M, Hasselblatt M, Eberhart C, Taylor MD.

Acta Neuropathol. 2010 Nov;120(5):553-66. doi: 10.1007/s00401-010-0751-5. Epub 2010 Sep 30. Review.

20.

What's new in neurofibromatosis? Proceedings from the 2009 NF Conference: new frontiers.

Kissil JL, Blakeley JO, Ferner RE, Huson SM, Kalamarides M, Mautner VF, McCormick F, Morrison H, Packer R, Ramesh V, Ratner N, Rauen KA, Stevenson DA, Hunter-Schaedle K, North K.

Am J Med Genet A. 2010 Feb;152A(2):269-83. doi: 10.1002/ajmg.a.33189.

Supplemental Content

Support Center